Stagflation is a new threat to the stock-market rally. What investors should know.
Read more at MarketWatch
Topics
-
The Fed’s job is not to boost the stock market. Here’s what it should be doing.
Getting inflation down to 2% should be the Fed’s No. 1 concern.MarketWatch - 2d -
My mother, 63, inherited $100,000. Is she too old to invest in the stock market? What should she do with it?
“Are the only options to create a CD ladder or leave it in a high-interest savings account?”MarketWatch - 3h -
Stock investors stopped freaking out over interest rates. Now this threat is re-emerging.
Investors appear to be doing a lot less hand-wringing over higher interest rates lately, but plenty of market risks are still coming up on the horizon.MarketWatch - 1d -
Market winners can fall hard — as investors in these favorite stocks found out
‘Magnificent Seven’ investors, take note.MarketWatch - 5h -
President Trump is losing the stock market war to the rest of the world so far. Here's where investors are taking advantage
Emerging market stocks, China and European stocks are beating U.S. indexes since the inauguration of Donald Trump.CNBC - 3d -
Texas measles cases are up, and New Mexico now has an outbreak. Here's what you need to know
The measles outbreak in rural West Texas has grown to 58 cases as of TuesdayABC News - 6d -
What might an optimistic investor buy in the UK?
The outlook is far from rosy, but what if we’re overdoing the doom and gloom?Financial Times - 3d -
Buy Nike’s stock aggressively as new CEO’s playbook should work, analyst says
Jefferies’ Randal Konik sees 50% upside in the stock, as he effectively calls a bottom in earnings and investor sentiment.MarketWatch - 9h -
Reporter's Notebook: A look back at 1939 Nazi rally in New York City
On this day in 1939, 20,000 people attended a Nazi rally at Madison Square Garden. Months earlier, Nazis in Germany had killed nearly 100 Jewish citizens in one night and sent 30,000 more to ...CBS News - 3d
More from MarketWatch
-
The ‘Magnificent Seven’ are out; these stocks are in — but there’s one catch
Japanese yen carry-trade unwind could again tank the stock market.MarketWatch - 17m -
Hims & Hers offers upbeat forecast, but stock slides after hours
Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s expectations, but shares fell hard in after-hours trading, in an echo ...MarketWatch - 28m -
In China you can get Ozempic and Wegovy within the hour for just $100 a month
Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of a button.MarketWatch - 35m -
‘A financial education is the best form of protest.’ This money pro shares her wealth-building secrets.
Tori Dunlap, founder of Her First $100K, wants you to be smart about spending and saving.MarketWatch - 44m -
Domino’s earnings missed on everything. Here’s why the quarter was still a win.
Domino’s saw carryout pizza sales increase but delivery sales fall, a sign its low-income customers are still hurting the most.MarketWatch - 44m
More in Business
-
The ‘Magnificent Seven’ are out; these stocks are in — but there’s one catch
Japanese yen carry-trade unwind could again tank the stock market.MarketWatch - 17m -
Voyage AI Just Sold for $220 Million—After Launching Less Than Two Years Ago
Here’s why acquirer MongoDB found the anti-hallucination tech particularly valuable.Inc. - 24m -
Hims & Hers offers upbeat forecast, but stock slides after hours
Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s expectations, but shares fell hard in after-hours trading, in an echo ...MarketWatch - 28m -
Starbucks to Lay Off 1,100 Corporate Workers
The jobs cuts, which will affect about 7 percent of the chain’s non-retail staff, are part of its new chief executive’s plan to win back customers.The New York Times - 29m -
In China you can get Ozempic and Wegovy within the hour for just $100 a month
Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of a button.MarketWatch - 35m